<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="iso-abbrev">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="publisher-id">rbccv</journal-id><journal-title-group><journal-title>Brazilian Journal of Cardiovascular Surgery</journal-title></journal-title-group><issn pub-type="ppub">0102-7638</issn><issn pub-type="epub">1678-9741</issn><publisher><publisher-name>Sociedade Brasileira de Cirurgia Cardiovascular</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">30652741</article-id><article-id pub-id-type="pmc">6326455</article-id><article-id pub-id-type="doi">10.21470/1678-9741-2018-0235</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Behavior of Ultrasensitive C-Reactive Protein in Myocardial
Revascularization with and without Cardiopulmonary Bypass</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Abrantes</surname><given-names>Rafael Diniz</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="c1"/><role>MD, MSc, PhD</role></contrib><contrib contrib-type="author"><name><surname>Hueb</surname><given-names>Alexandre Ciappina</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><role>MD, PhD</role></contrib><contrib contrib-type="author"><name><surname>Hueb</surname><given-names>Whady</given-names></name><xref ref-type="aff" rid="aff2">2</xref><role>MD, PhD</role></contrib><contrib contrib-type="author"><name><surname>Jatene</surname><given-names>Fabio B.</given-names></name><xref ref-type="aff" rid="aff2">2</xref><role>MD, PhD</role></contrib></contrib-group><aff id="aff1">
<label>1</label> Cardiovascular Surgery Division, Hospital das Cl&#x000ed;nicas
Samuel Lib&#x000e2;nio (HCSL), Pouso Alegre, MG, Brazil. </aff><aff id="aff2">
<label>2</label> Cardiovascular Surgery Division, Instituto do Cora&#x000e7;&#x000e3;o
do Hospital das Cl&#x000ed;nicas da Faculdade de Medicina da Universidade de
S&#x000e3;o Paulo (InCor-HCFMUSP), S&#x000e3;o Paulo, SP, Brazil. </aff><author-notes><corresp id="c1">Correspondence Address: Rafael Diniz Abrantes, Rua Comendador
Jos&#x000e9; Garcia, 777 - Centro - Pouso Alegre, MG, Brazil, Zip code:
37550-000. E-mail: <email>rafaelcardio@gmail.com</email></corresp></author-notes><pub-date pub-type="epub-ppub"><season>Nov-Dec</season><year>2018</year></pub-date><!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' --><pub-date pub-type="ppub"><season>Nov-Dec</season><year>2018</year></pub-date><volume>33</volume><issue>6</issue><fpage>535</fpage><lpage>541</lpage><history><date date-type="received"><day>12</day><month>8</month><year>2018</year></date><date date-type="accepted"><day>31</day><month>8</month><year>2018</year></date></history><permissions><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an Open Access article distributed under the terms of the
Creative Commons Attribution License, which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is
properly cited.</license-p></license></permissions><abstract><sec><title>Objective</title><p>To analyze the inflammation resulting from myocardial revascularization
techniques with and without cardiopulmonary bypass, based on ultrasensitive
C-reactive protein (US-CRP) behavior.</p></sec><sec><title>Methods</title><p>A prospective non-randomized clinical study with 136 patients was performed.
Sixty-nine patients were enrolled for Group 1 (on-pump coronary artery
bypass - ONCAB) and 67 patients were assigned to Group 2 (off-pump coronary
artery bypass - OPCAB). All study participants had blood samples collected
for analysis of glucose, triglycerides, creatinine, total cholesterol,
high-density lipoprotein (HDL), low-density lipoprotein (LDL) and
creatinephosphokinase (CPK) in the preoperative period. The samples of
creatinephosphokinase MB (CKMB), troponin I (TnI) and US-CRP were collected
in the preoperative period and at 6, 12, 24, 36, 48 and 72 hours after
surgery. We also analyzed the preoperative biological variables of each
patient (age, smoking, diabetes mellitus, left coronary trunk lesion, body
mass index, previous myocardial infarction, myocardial fibrosis). All
angiographically documented patients with &#x0003e;70% proximal multiarterial
stenosis and ischemia, documented by stress test or classification of stable
angina (class II or III), according to the Canadian Cardiovascular Society,
were included. Reoperations, combined surgeries, recent acute myocardial
infarction, recent inflammatory disease, deep venous thrombosis or recent
pulmonary thromboembolism, acute kidney injury or chronic kidney injury were
not included.</p></sec><sec><title>Results</title><p>Correlation values between the US-CRP curve and the ONCAB group, the
treatment effect and the analyzed biological variables did not present
expressive results. Laboratory variables were evaluated and did not
correlate with the applied treatment (<italic>P</italic>&#x0003e;0.05).</p></sec><sec><title>Conclusion</title><p>The changes in the US-CRP at each moment evaluated from the postoperative
period did not show any significance in relation to the surgical technique
applied.</p></sec></abstract><kwd-group><kwd>C-Reactive Protein</kwd><kwd>Atherosclerosis</kwd><kwd>Myocardial Revascularization</kwd><kwd>Coronary Artery Bypass</kwd><kwd>Coronary Artery Bypass, Off-Pump</kwd><kwd>Inflammation</kwd><kwd>Cardiopulmonary Bypass</kwd></kwd-group></article-meta></front><body><table-wrap id="t2" orientation="portrait" position="anchor"><table frame="hsides" rules="groups"><colgroup span="1"><col width="10%" span="1"/><col width="38%" span="1"/><col width="05%" span="1"/><col width="10%" span="1"/><col width="37%" span="1"/></colgroup><thead><tr><th align="left" colspan="2" style="background-color:#eaeaea" rowspan="1">Abbreviations,
acronyms &#x00026; symbols</th><th align="center" rowspan="1" colspan="1">&#x000a0;</th><th align="center" colspan="2" style="background-color:#eaeaea" rowspan="1">&#x000a0;</th></tr></thead><tbody><tr><td align="left" style="background-color:#eaeaea" rowspan="1" colspan="1"><bold>AKI</bold></td><td align="left" style="background-color:#eaeaea" rowspan="1" colspan="1"><bold>= Acute kidney
injury</bold></td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#eaeaea" rowspan="1" colspan="1"><bold>HDL</bold></td><td align="left" style="background-color:#eaeaea" rowspan="1" colspan="1"><bold>= High-density
lipoprotein</bold></td></tr><tr><td align="left" style="background-color:#eaeaea" rowspan="1" colspan="1"><bold>AMI</bold></td><td align="left" style="background-color:#eaeaea" rowspan="1" colspan="1"><bold>= Anterior
myocardial infarction</bold></td><td align="left" style="background-color:white" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#eaeaea" rowspan="1" colspan="1"><bold>KF</bold></td><td align="left" style="background-color:#eaeaea" rowspan="1" colspan="1"><bold>= Kidney
failure</bold></td></tr><tr><td align="left" style="background-color:#eaeaea" rowspan="1" colspan="1"><bold>BMI</bold></td><td align="left" style="background-color:#eaeaea" rowspan="1" colspan="1"><bold>= Body mass
index</bold></td><td align="left" style="background-color:white" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#eaeaea" rowspan="1" colspan="1"><bold>LCT</bold></td><td align="left" style="background-color:#eaeaea" rowspan="1" colspan="1"><bold>= Left coronary
trunk lesion</bold></td></tr><tr><td align="left" style="background-color:#eaeaea" rowspan="1" colspan="1"><bold>CABG</bold></td><td align="left" style="background-color:#eaeaea" rowspan="1" colspan="1"><bold>= Coronary artery
bypass grafting</bold></td><td align="left" style="background-color:white" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#eaeaea" rowspan="1" colspan="1"><bold>LDL</bold></td><td align="left" style="background-color:#eaeaea" rowspan="1" colspan="1"><bold>= Low-density
lipoprotein</bold></td></tr><tr><td align="left" style="background-color:#eaeaea" rowspan="1" colspan="1"><bold>CAD</bold></td><td align="left" style="background-color:#eaeaea" rowspan="1" colspan="1"><bold>= Coronary artery
disease</bold></td><td align="left" style="background-color:white" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#eaeaea" rowspan="1" colspan="1"><bold>LVEF</bold></td><td align="left" style="background-color:#eaeaea" rowspan="1" colspan="1"><bold>= Left ventricular
ejection fraction</bold></td></tr><tr><td align="left" style="background-color:#eaeaea" rowspan="1" colspan="1"><bold>CCS</bold></td><td align="left" style="background-color:#eaeaea" rowspan="1" colspan="1"><bold>= Canadian
Cardiovascular Society</bold></td><td align="left" style="background-color:white" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#eaeaea" rowspan="1" colspan="1"><bold>MI</bold></td><td align="left" style="background-color:#eaeaea" rowspan="1" colspan="1"><bold>= Myocardial
infarction</bold></td></tr><tr><td align="left" style="background-color:#eaeaea" rowspan="1" colspan="1"><bold>CKMB</bold></td><td align="left" style="background-color:#eaeaea" rowspan="1" colspan="1"><bold>=
Creatinephosphokinase MB</bold></td><td align="left" style="background-color:white" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#eaeaea" rowspan="1" colspan="1"><bold>ONCAB</bold></td><td align="left" style="background-color:#eaeaea" rowspan="1" colspan="1"><bold>= On-pump coronary
artery bypass</bold></td></tr><tr><td align="left" style="background-color:#eaeaea" rowspan="1" colspan="1"><bold>CMR</bold></td><td align="left" style="background-color:#eaeaea" rowspan="1" colspan="1"><bold>= Cardiac magnetic
resonance</bold></td><td align="left" style="background-color:white" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#eaeaea" rowspan="1" colspan="1"><bold>OPCAB</bold></td><td align="left" style="background-color:#eaeaea" rowspan="1" colspan="1"><bold>= Off-pump coronary
artery bypass</bold></td></tr><tr><td align="left" style="background-color:#eaeaea" rowspan="1" colspan="1"><bold>CPB</bold></td><td align="left" style="background-color:#eaeaea" rowspan="1" colspan="1"><bold>= Cardiopulmonary
bypass</bold></td><td align="left" style="background-color:white" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#eaeaea" rowspan="1" colspan="1"><bold>PTE</bold></td><td align="left" style="background-color:#eaeaea" rowspan="1" colspan="1"><bold>= Pulmonary
thromboembolism</bold></td></tr><tr><td align="left" style="background-color:#eaeaea" rowspan="1" colspan="1"><bold>CPK</bold></td><td align="left" style="background-color:#eaeaea" rowspan="1" colspan="1"><bold>=
Creatinephosphokinase</bold></td><td align="left" style="background-color:white" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#eaeaea" rowspan="1" colspan="1"><bold>SAH</bold></td><td align="left" style="background-color:#eaeaea" rowspan="1" colspan="1"><bold>= Systolic arterial
hypertension</bold></td></tr><tr><td align="left" style="background-color:#eaeaea" rowspan="1" colspan="1"><bold>CKI</bold></td><td align="left" style="background-color:#eaeaea" rowspan="1" colspan="1"><bold>= Chronic kidney
injury</bold></td><td align="left" style="background-color:white" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#eaeaea" rowspan="1" colspan="1"><bold>SIRS</bold></td><td align="left" style="background-color:#eaeaea" rowspan="1" colspan="1"><bold>= Systemic
inflammatory response syndrome</bold></td></tr><tr><td align="left" style="background-color:#eaeaea" rowspan="1" colspan="1"><bold>CRP</bold></td><td align="left" style="background-color:#eaeaea" rowspan="1" colspan="1"><bold>= C-reactive
protein</bold></td><td align="left" style="background-color:white" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#eaeaea" rowspan="1" colspan="1"><bold>ST</bold></td><td align="left" style="background-color:#eaeaea" rowspan="1" colspan="1"><bold>= Stress
test</bold></td></tr><tr><td align="left" style="background-color:#eaeaea" rowspan="1" colspan="1"><bold>CVA</bold></td><td align="left" style="background-color:#eaeaea" rowspan="1" colspan="1"><bold>= Cerebrovascular
accident</bold></td><td align="left" style="background-color:white" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#eaeaea" rowspan="1" colspan="1"><bold>TC</bold></td><td align="left" style="background-color:#eaeaea" rowspan="1" colspan="1"><bold>= Total
cholesterol</bold></td></tr><tr><td align="left" style="background-color:#eaeaea" rowspan="1" colspan="1"><bold>CVEs</bold></td><td align="left" style="background-color:#eaeaea" rowspan="1" colspan="1"><bold>= Cardiovascular
events</bold></td><td align="left" style="background-color:white" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#eaeaea" rowspan="1" colspan="1"><bold>TG</bold></td><td align="left" style="background-color:#eaeaea" rowspan="1" colspan="1"><bold>=
Triglycerides</bold></td></tr><tr><td align="left" style="background-color:#eaeaea" rowspan="1" colspan="1"><bold>DM</bold></td><td align="left" style="background-color:#eaeaea" rowspan="1" colspan="1"><bold>= Diabetes
mellitus</bold></td><td align="left" style="background-color:white" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#eaeaea" rowspan="1" colspan="1"><bold>TnI</bold></td><td align="left" style="background-color:#eaeaea" rowspan="1" colspan="1"><bold>= Troponin
I</bold></td></tr><tr><td align="left" style="background-color:#eaeaea" rowspan="1" colspan="1"><bold>DVT</bold></td><td align="left" style="background-color:#eaeaea" rowspan="1" colspan="1"><bold>= Deep vein
thrombosis</bold></td><td align="left" style="background-color:white" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#eaeaea" rowspan="1" colspan="1"><bold>US-CRP</bold></td><td align="left" style="background-color:#eaeaea" rowspan="1" colspan="1"><bold>= Ultrasensitive
C-reactive protein</bold></td></tr></tbody></table></table-wrap><sec sec-type="intro"><title>INTRODUCTION</title><p>In 1930, Tillet and Francis<sup>[<xref rid="r1" ref-type="bibr">1</xref>]</sup> published the first report on the occasional
discovery of C-reactive protein (CRP). In 1943, the first clues to the possible
connection between CRP and atherothrombotic events were described by
Lofstrom<sup>[<xref rid="r2" ref-type="bibr">2</xref>]</sup> and later by Kroop and
Shackman<sup>[<xref rid="r3" ref-type="bibr">3</xref>]</sup>, in the mid-1950s.</p><p>But it was in the mid-1990s, through immunoassays, that this protein with a
pentameric structure gained considerable worldwide interest when its prognostic
involvement for future cardiovascular events (CVEs) was
published<sup>[<xref rid="r4" ref-type="bibr">4</xref>]</sup>. Recent studies have shown the central role of
inflammation in coronary artery disease (CAD)<sup>[<xref rid="r5" ref-type="bibr">5</xref>]</sup>, as well as its influence on the
instability of the coronary plaques causing acute CVEs<sup>[<xref rid="r6" ref-type="bibr">6</xref>,<xref rid="r7" ref-type="bibr">7</xref>]</sup>. This latter
characteristic emphasizes the utmost importance for this work in the choice of the
ultrasensitive C-reactive protein (US-CRP) for the evaluation of the inflammatory
profile resulting from on-pump coronary artery bypass (ONCAB) and off-pump coronary
artery bypass (OPCAB).</p><p>Even with all the advances achieved in cardiovascular surgery, the circuit used for
cardiopulmonary bypass (CPB) still leads to perioperative and postoperative
disorders, the most common being the systemic inflammatory response syndrome (SIRS),
and coagulation disorders<sup>[<xref rid="r8" ref-type="bibr">8</xref>,<xref rid="r9" ref-type="bibr">9</xref>]</sup>.</p><p>The injuries caused by CPB during the surgical procedure motivated a great deal of
interest in recent studies on OPCAB, pioneered by Kolessov<sup>[<xref rid="r10" ref-type="bibr">10</xref>]</sup>, in 1964. Following
the hypothetical current of CPB withdrawal to minimize the risks of the surgical
procedure<sup>[<xref rid="r11" ref-type="bibr">11</xref>]</sup>, some initial series of patients undergoing OPCAB
were published, with a special nod to Buffolo et al.<sup>[<xref rid="r12" ref-type="bibr">12</xref>-<xref rid="r14" ref-type="bibr">14</xref>]</sup>, in Brazil, and
Benetti et al.<sup>[<xref rid="r15" ref-type="bibr">15</xref>]</sup>, in Argentina.</p><p>Biomolecular studies have deepened in recent decades, revealing more details of the
inflammatory pathophysiology caused to the human body by CPB. This has become a
major attempt to intuitively show that OPCAB has greater benefits for patients.</p><p>Cochrane database<sup>[<xref rid="r16" ref-type="bibr">16</xref>]</sup>, in contrast to the new trend of thought, disclosed
its data showing a higher long-term mortality of OPCAB after a systematic review.
Large trials such as MASS-III<sup>[<xref rid="r17" ref-type="bibr">17</xref>]</sup>, ROOBY<sup>[<xref rid="r18" ref-type="bibr">18</xref>]</sup>, DOORS<sup>[<xref rid="r19" ref-type="bibr">19</xref>]</sup>,
GOPCABE<sup>[<xref rid="r20" ref-type="bibr">20</xref>]</sup> and CORONARY<sup>[<xref rid="r21" ref-type="bibr">21</xref>-<xref rid="r24" ref-type="bibr">24</xref>]</sup>, which evaluated the comparative results
between the techniques with and without CPB, had, as their primary outcomes,
mortality, nonfatal myocardial infarction (MI), cerebrovascular accident (CVA) and
kidney failure (KF) with a need for dialysis. However, literature does not present
reports comparing the inflammatory profile triggered by the two techniques under
trial.</p><p>With so many studies and results often contradictory, biological markers become
increasingly important in trying to explain the impact caused by one or another
surgical technique. And this will be the aim of this work: to evaluate systemic
inflammation and its effects through the behavior of US-CRP in ONCAB or OPCAB.</p></sec><sec sec-type="methods"><title>METHODS</title><p>Between May 2012 and March 2014, 326 prospective, nonrandomized patients were
eligible for coronary artery bypass grafting (CABG) in a single center, and 219 were
included in this trial. The main reasons for the exclusion of 107 patients are
presented in <xref ref-type="fig" rid="f1">Figure 1</xref>. Of the included
patients, 148 were divided into two groups. In Group 1, 75 patients were assigned to
undergo ONCAB, and in Group 2, 73 were assigned to undergo OPCAB (<xref ref-type="fig" rid="f1">Figure 1</xref>).</p><p>
<fig id="f1" orientation="portrait" position="float"><label>Fig. 1</label><caption><p>Diagram of MASS-V Trial participants. CMR - Cardiac magnetic
resonance.</p></caption><graphic xlink:href="rbccv-33-06-0535-g01"/><attrib>Source: Modified figure of Hueb et al<sup>[<xref rid="r25" ref-type="bibr">25</xref>]</sup>.</attrib></fig>
</p><p>The groups were considered comparable according to the biological and laboratorial
variables analyzed, except for the greater occurrence of systolic arterial
hypertension (SAH) in Group 1 and acute myocardial infarction (AMI) in Group 2
(<xref rid="t1" ref-type="table">Table 1</xref>).</p><table-wrap id="t1" orientation="portrait" position="float"><label>Table 1</label><caption><p>Descriptive values of the evaluated variables.</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="14%" span="1"/><col width="14%" span="1"/><col width="16%" span="1"/><col width="19%" span="1"/><col width="19%" span="1"/><col width="14%" span="1"/></colgroup><thead><tr><th align="left" colspan="2" rowspan="2">Variable</th><th align="center" rowspan="2" colspan="1">Sample<break/>(n=136)</th><th align="center" colspan="2" rowspan="1">Groups</th><th align="center" rowspan="2" colspan="1"><italic>P</italic></th></tr><tr><th rowspan="1" colspan="1">With CPB (n=69)</th><th rowspan="1" colspan="1">Without CPB (n=67)</th></tr></thead><tbody><tr><td align="left" colspan="2" rowspan="1">Age (years)</td><td align="center" rowspan="1" colspan="1">62.19&#x000b1;9.26</td><td align="center" rowspan="1" colspan="1">61.71&#x000b1;8.60</td><td align="center" rowspan="1" colspan="1">62.69&#x000b1;9.94</td><td align="center" rowspan="1" colspan="1">0.541<xref ref-type="table-fn" rid="TFN02"><sup>1</sup></xref></td></tr><tr><td align="left" colspan="2" rowspan="1">Age &#x0003c;70 years</td><td align="center" rowspan="1" colspan="1">104 (76.5%)</td><td align="center" rowspan="1" colspan="1">54 (78.3%)</td><td align="center" rowspan="1" colspan="1">50 (74.6%)</td><td align="center" rowspan="1" colspan="1">0.617<xref ref-type="table-fn" rid="TFN03"><sup>2</sup></xref></td></tr><tr><td align="left" colspan="2" rowspan="1">Gender: male</td><td align="center" rowspan="1" colspan="1">93 (68.4%)</td><td align="center" rowspan="1" colspan="1">48 (69.6%)</td><td align="center" rowspan="1" colspan="1">45 (67.2%)</td><td align="center" rowspan="1" colspan="1">0.763<xref ref-type="table-fn" rid="TFN03"><sup>2</sup></xref></td></tr><tr><td align="left" colspan="2" rowspan="1">BMI (kg/m<sup>2</sup>)</td><td align="center" rowspan="1" colspan="1">28.11&#x000b1;4.34</td><td align="center" rowspan="1" colspan="1">28.68&#x000b1;4.44</td><td align="center" rowspan="1" colspan="1">27.53&#x000b1;4.20</td><td align="center" rowspan="1" colspan="1">0.122<xref ref-type="table-fn" rid="TFN02"><sup>1</sup></xref></td></tr><tr><td align="left" colspan="2" rowspan="1">LCT lesion</td><td align="center" rowspan="1" colspan="1">40 (29.4%)</td><td align="center" rowspan="1" colspan="1">21 (30,4%)</td><td align="center" rowspan="1" colspan="1">19 (28.4%)</td><td align="center" rowspan="1" colspan="1">0.791<xref ref-type="table-fn" rid="TFN03"><sup>2</sup></xref></td></tr><tr><td align="left" rowspan="6" colspan="1">Coronary</td><td align="left" rowspan="1" colspan="1">One</td><td align="center" rowspan="1" colspan="1">1 (0.7%)</td><td align="center" rowspan="1" colspan="1">___</td><td align="center" rowspan="1" colspan="1">1 (1.5%)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">Two</td><td align="center" rowspan="1" colspan="1">33 (24.3%)</td><td align="center" rowspan="1" colspan="1">14 (20.3%)</td><td align="center" rowspan="1" colspan="1">19 (28.4%)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">Three</td><td align="center" rowspan="1" colspan="1">102 (75%)</td><td align="center" rowspan="1" colspan="1">55 (79.7%)</td><td align="center" rowspan="1" colspan="1">47 (70.2%)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">LADA (%)</td><td align="center" rowspan="1" colspan="1">79.54&#x000b1;16.94</td><td align="center" rowspan="1" colspan="1">81.61&#x000b1;15.69</td><td align="center" rowspan="1" colspan="1">77.40&#x000b1;18</td><td align="center" rowspan="1" colspan="1">0.148<xref ref-type="table-fn" rid="TFN02"><sup>1</sup></xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Cx &#x000a0;(%)</td><td align="center" rowspan="1" colspan="1">77.13&#x000b1;20.03</td><td align="center" rowspan="1" colspan="1">80.36&#x000b1;16.56</td><td align="center" rowspan="1" colspan="1">73.46&#x000b1;22.95</td><td align="center" rowspan="1" colspan="1">0.059<xref ref-type="table-fn" rid="TFN02"><sup>1</sup></xref></td></tr><tr><td align="left" rowspan="1" colspan="1">RC &#x000a0;(%)</td><td align="center" rowspan="1" colspan="1">81.42&#x000b1;21.96</td><td align="center" rowspan="1" colspan="1">80.74&#x000b1;21.96</td><td align="center" rowspan="1" colspan="1">82.17&#x000b1;22.11</td><td align="center" rowspan="1" colspan="1">0.718<xref ref-type="table-fn" rid="TFN02"><sup>1</sup></xref></td></tr><tr><td align="left" rowspan="3" colspan="1">Smoking</td><td align="left" rowspan="1" colspan="1">Yes</td><td align="center" rowspan="1" colspan="1">36 (26.5%)</td><td align="center" rowspan="1" colspan="1">23 (33.3%)</td><td align="center" rowspan="1" colspan="1">13 (19.4%)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">Ex</td><td align="center" rowspan="1" colspan="1">74 (54.4%)</td><td align="center" rowspan="1" colspan="1">37 (53.6%)</td><td align="center" rowspan="1" colspan="1">37 (55.2%)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">No</td><td align="center" rowspan="1" colspan="1">26 (19.1%)</td><td align="center" rowspan="1" colspan="1">9 (13.1%)</td><td align="center" rowspan="1" colspan="1">17 (25.4%)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" colspan="2" rowspan="1">Prior AMI</td><td align="center" rowspan="1" colspan="1">43 (31.6%)</td><td align="center" rowspan="1" colspan="1">16 (23.2%)</td><td align="center" rowspan="1" colspan="1">27 (40.3%)</td><td align="center" rowspan="1" colspan="1">0.032<xref ref-type="table-fn" rid="TFN03"><sup>2</sup></xref></td></tr><tr><td align="left" colspan="2" rowspan="1">SAH</td><td align="center" rowspan="1" colspan="1">116 (85.3%)</td><td align="center" rowspan="1" colspan="1">63 (91.3%)</td><td align="center" rowspan="1" colspan="1">53 (79.1%)</td><td align="center" rowspan="1" colspan="1">0.045<xref ref-type="table-fn" rid="TFN03"><sup>2</sup></xref></td></tr><tr><td align="left" colspan="2" rowspan="1">DM</td><td align="center" rowspan="1" colspan="1">68 (50%)</td><td align="center" rowspan="1" colspan="1">33 (47.8%)</td><td align="center" rowspan="1" colspan="1">35 (52.2%)</td><td align="center" rowspan="1" colspan="1">0.607<xref ref-type="table-fn" rid="TFN03"><sup>2</sup></xref></td></tr><tr><td align="left" rowspan="5" colspan="1">Angina (degree)</td><td align="left" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">16 (11.8%)</td><td align="center" rowspan="1" colspan="1">8 (11.6%)</td><td align="center" rowspan="1" colspan="1">8 (11.9%)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">18 (13.2%)</td><td align="center" rowspan="1" colspan="1">8 (11.6%)</td><td align="center" rowspan="1" colspan="1">10 (14.9%)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">60 (44.1%)</td><td align="center" rowspan="1" colspan="1">33 (47.8%)</td><td align="center" rowspan="1" colspan="1">27 (40.3%)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">28 (20.6%)</td><td align="center" rowspan="1" colspan="1">12 (17.4%)</td><td align="center" rowspan="1" colspan="1">16 (23.9%)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">14 (10.3%)</td><td align="center" rowspan="1" colspan="1">8 (11.6%)</td><td align="center" rowspan="1" colspan="1">6 (9%)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" colspan="2" rowspan="1">Cholesterol</td><td align="center" rowspan="1" colspan="1">167.47&#x000b1;45.67</td><td align="center" rowspan="1" colspan="1">162.23&#x000b1;39.36</td><td align="center" rowspan="1" colspan="1">173.03&#x000b1;51.25</td><td align="center" rowspan="1" colspan="1">0.176<xref ref-type="table-fn" rid="TFN02"><sup>1</sup></xref></td></tr><tr><td align="left" colspan="2" rowspan="1">LDL</td><td align="center" rowspan="1" colspan="1">97.75&#x000b1;37.27</td><td align="center" rowspan="1" colspan="1">95.07&#x000b1;34.64</td><td align="center" rowspan="1" colspan="1">100.60&#x000b1;39.94</td><td align="center" rowspan="1" colspan="1">0.393<xref ref-type="table-fn" rid="TFN02"><sup>1</sup></xref></td></tr><tr><td align="left" colspan="2" rowspan="1">HDL</td><td align="center" rowspan="1" colspan="1">38.27&#x000b1;12.17</td><td align="center" rowspan="1" colspan="1">38.51&#x000b1;12</td><td align="center" rowspan="1" colspan="1">38.02&#x000b1;12.44</td><td align="center" rowspan="1" colspan="1">0.816<xref ref-type="table-fn" rid="TFN02"><sup>1</sup></xref></td></tr><tr><td align="left" colspan="2" rowspan="1">TG</td><td align="center" rowspan="1" colspan="1">163.64&#x000b1;125.25</td><td align="center" rowspan="1" colspan="1">154.57&#x000b1;134.34</td><td align="center" rowspan="1" colspan="1">173.28&#x000b1;115.08</td><td align="center" rowspan="1" colspan="1">0.390<xref ref-type="table-fn" rid="TFN02"><sup>1</sup></xref></td></tr><tr><td align="left" colspan="2" rowspan="1">Glucose</td><td align="center" rowspan="1" colspan="1">134.04&#x000b1;52.77</td><td align="center" rowspan="1" colspan="1">134.32&#x000b1;54.28</td><td align="center" rowspan="1" colspan="1">133.76&#x000b1;51.57</td><td align="center" rowspan="1" colspan="1">0.951<xref ref-type="table-fn" rid="TFN02"><sup>1</sup></xref></td></tr><tr><td align="left" colspan="2" rowspan="1">Creatinine</td><td align="center" rowspan="1" colspan="1">1.04&#x000b1;0.27</td><td align="center" rowspan="1" colspan="1">1.05&#x000b1;0.28</td><td align="center" rowspan="1" colspan="1">1.03&#x000b1;0.26</td><td align="center" rowspan="1" colspan="1">0.556<xref ref-type="table-fn" rid="TFN02"><sup>1</sup></xref></td></tr><tr><td align="left" colspan="2" rowspan="1">Preoperative fibrosis</td><td align="center" rowspan="1" colspan="1">3.64&#x000b1;5.63</td><td align="center" rowspan="1" colspan="1">4.42&#x000b1;6.61</td><td align="center" rowspan="1" colspan="1">2.60&#x000b1;4.80</td><td align="center" rowspan="1" colspan="1">0.111<xref ref-type="table-fn" rid="TFN05"><sup>4</sup></xref></td></tr><tr><td align="left" colspan="2" rowspan="1">Postoperative fibrosis</td><td align="center" rowspan="1" colspan="1">5.75&#x000b1;6.56</td><td align="center" rowspan="1" colspan="1">6.16&#x000b1;6.69</td><td align="center" rowspan="1" colspan="1">5.22&#x000b1;6.42</td><td align="center" rowspan="1" colspan="1">0.508<xref ref-type="table-fn" rid="TFN05"><sup>4</sup></xref></td></tr></tbody></table><table-wrap-foot><fn id="TFN01"><p>AMI=acute myocardial infarction; BMI=body mass index; CPB=cardiopulmonary
bypass; Cx=circumflex artery; DM=diabetes mellitus; LADA=left anterior
descending artery; LCT=left coronary trunk lesion; RC=right coronary
artery; SAH=systolic arterial hypertension; TG=tryglicerides</p></fn><fn id="TFN02"><label>1</label><p>Descriptive level of probability of Student's t-test.</p></fn><fn id="TFN03"><label>2</label><p>Descriptive level of probability of the chi-square test.</p></fn><fn id="TFN04"><label>3</label><p>Descriptive level of probability of the Fisher&#x02019;s exact test.</p></fn><fn id="TFN05"><label>4</label><p>Descriptive level of probability of the Mann-Whitney non-parametric
test.</p></fn></table-wrap-foot></table-wrap><p>Of all these patients, 12 were excluded (7 for claustrophobia on cardiac magnetic
resonance - CMR, 3 for stroke and 2 for sepsis). The remaining 136 patients were
divided into 2 groups with 69 patients assigned to Group 1 and 67 to Group 2 (<xref ref-type="fig" rid="f2">Figure 2</xref>). All participants in the study had
blood samples collected for the analysis of glucose, triglycerides (TG), creatinine,
total cholesterol (TC), high-density lipoprotein (HDL), low-density lipoprotein
(LDL) and creatinephosphokinase (CPK) in the preoperative period. The samples of
creatinephosphokinase MB (CKMB), troponin I (TnI) and US-CRP were collected in the
preoperative period and after 6, 12, 24, 36, 48, and 72 hours from the surgery. The
laboratory analysis provided the US-CRP that was analyzed in a univariate and
bivariate way. We also analyzed in the preoperative biological variables of each
patient [age, smoking, diabetes mellitus (DM), left coronary trunk lesion (LCT),
body mass index (BMI), previous MI, myocardial fibrosis]. The presence of myocardial
fibrosis was analyzed by CMR 2 days before surgery (F1= preoperative fibrosis) and 6
days after surgery (F2= postoperative fibrosis). All angiographically documented
patients with &#x0003e;70% proximal multiarterial stenosis and ischemia, documented by
stress test (ST) or classification of stable angina (Class II or III), according to
the Canadian Cardiovascular Society (CCS), were included. Reoperations, combined
surgeries, recent AMI (&#x02264;6 months), recent inflammatory disease, deep vein
thrombosis (DVT) or recent pulmonary thromboembolism (PTE), acute kidney injury
(AKI), or chronic kidney injury (CKI), were not included.</p><p>
<fig id="f2" orientation="portrait" position="float"><label>Fig. 2</label><caption><p>Behavior of the usCRP during the moments evaluated in the groups with and
without CPB.</p></caption><graphic xlink:href="rbccv-33-06-0535-g02"/></fig>
</p></sec><sec sec-type="results"><title>RESULTS</title><p>It was observed that there was an increase in the US-CRP values obtained in the
postoperative period in relation to the preoperative period
(<italic>P</italic>&#x0003c;0.001). This change was significant in relation to the
myocardial revascularization techniques employed. A bivariate analysis correlated
the area under the US-CRP curve and the other variables analyzed and no statistical
significance was observed (<italic>P</italic>&#x0003e;0.05), except for the CPK curve
that resulted in a positive correlation in Group 1 (<italic>P</italic>=0.015). <xref ref-type="fig" rid="f2">Figure 2</xref> shows the behavior of the us-CRP at each
evaluated moment.</p><p>The plasma concentration of US-CRP varied over time in the postoperative period (6h,
12h, 24h, 36, 48h and 72h) and its association with the other variables was assessed
by calculating the area below the curve of each patient.</p><p>The US-CRP of the patients evaluated at each moment did not present statistical
difference in the studied groups (<italic>P</italic>=0.867). The means of
evaluations in Group 1 and Group 2 are represented in <xref ref-type="fig" rid="f3">Figure 3</xref>.</p><p>
<fig id="f3" orientation="portrait" position="float"><label>Fig. 3</label><caption><p>Association of the area under usCRP curve in the studied groups.</p></caption><graphic xlink:href="rbccv-33-06-0535-g03"/></fig>
</p></sec><sec sec-type="discussion"><title>DISCUSSION</title><p>The results observed in this study were surprising because it is understood that the
maintenance of a non-physiological condition, such as CPB, even for a short period,
should in some way exacerbate the systemic inflammatory system.</p><p>However, it was identified that the use or not of CPB in patients undergoing CABG,
being of the same demographic profile, was not the trigger of the inflammatory
response identified by US-CRP. It is interesting to observe that the world
literature lacks information on US-CRP as a marker of the inflammatory response in
the comparison between ONCAB and OPCAB.</p><p>The fact is that several well-conducted studies and trials have identified its
elevation, but in conditions where there are already predictive variables of
elevated or altered systemic injuries<sup>[<xref rid="r26" ref-type="bibr">26</xref>]</sup>.</p><p>Other studies, such as that of Nezami et al.<sup>[<xref rid="r27" ref-type="bibr">27</xref>]</sup>, showed that there was no evolutionary
difference in patients submitted to ONCAB or OPCAB, mainly in kidney injury, when
US-CRP was assessed.</p><p>In this study, we were able to identify that CPB was not the variable that
exacerbated this response, at least under the aspect of US-CRP behavior.</p><p>This assertion is corroborated by the fact that, in the postoperative period, we
identified a marked increase in US-CRP, as shown in the results, specifically in
<xref ref-type="fig" rid="f2">Figure 2</xref>, which assesses the US-CRP
evolution times.</p><p>In the 12<sup>th</sup> hour, one can observe an increase 40 times greater in the
US-CRP baseline. In the 48<sup>th</sup> postoperative hour, we identified an US-CRP
maximum peak, which was almost 100 times the baseline value. However, an interesting
point was a similar behavior of US-CRP in patients undergoing ONCAB or OPCAB.</p><p>Therefore, we can infer that the inflammatory response was triggered in the
postoperative period. In fact, up to 72 hours postoperatively, US-CRP levels still
remained very high, but without any difference across the groups. That is, CPB was
not the most important variable, as a trigger of the inflammatory response.</p><p>In the present study, the idea that the postoperative inflammatory response can be
minimized by the non-use of CPB was not supported by the prism of the behavior of
US-CRP, which is undoubtedly an important marker of the inflammatory response.</p><p>In fact, as pointed out, there are few studies comparing the US-CRP behavior and
predictive value in patients undergoing ONCAB or OPCAB. In order to assure the
validity of the study, we opted to equalize preoperative demographic variables.
Moreover, statistical analyzes segmented the arms according to profiles that could
interfere with the results.</p><p>Our results were based on univariate and bivariate analyzes regarding the CPB
behavior over time and the treatments applied to the groups on or off-pump, thus
guaranteeing greater robustness and consistency to the present work.</p><p>We observed that, unlike other variables, CPK showed a positive and significant
correlation when analyzed with the area of the US-CRP curve in the ONCAB group
(<italic>P</italic>=0.015). Therefore, the higher the CPK value, the greater the
value of the area under the curve of US-CRP and vice versa. In the OPCAB group we
did not observe a significant correlation between these variables
(<italic>P</italic>=0.761).</p><p>Gerritsen et al.<sup>[<xref rid="r28" ref-type="bibr">28</xref>]</sup> compared patients undergoing ONCAB or OPCAB and
identified a worsening of the renal function in patients submitted to ONCAB.</p><p>Loef et al.<sup>[<xref rid="r29" ref-type="bibr">29</xref>]</sup> identified signs of increased oxidative stress, as
measured by urinary concentrations of hypoxanthine, xanthine, and malondialdehyde in
the ONCAB group, while only minor changes were reported in the OPCAB group.</p><p>Data derived from the study carried out by Hueb et al.<sup>[<xref rid="r25" ref-type="bibr">25</xref>]</sup>, in MASS V,
specifically analyzing renal function, did not reveal alterations in renal function
when the ONCAB or OPCAB groups were compared.</p><p>These insignificant changes in renal function were not connected to inflammatory
markers. In our analyzes, we observed that there was no significant correlation
between creatinine and the area of the US-CRP curve in the group with or without CPB
(<italic>P</italic>=0.797).</p><p>Another very relevant aspect in the postoperative CABG is related to the injury that
may develop in the myocardium. In this sense, we were careful to analyze the
behavior of the myocardial necrosis markers together with US-CRP in the
postoperative period.</p><p>We analyzed the area under the US-CRP curve and the peak plasma concentration of CKMB
and troponin (I) and there was no difference in these biomarkers in the
postoperative period, either in Group 1 or in Group 2. Many inflammatory triggers
could influence the US-CRP behavior.</p><p>In the attempt to avoid bias, there was great concern in the identification and
influence of biological variables (age, smoking, BMI, LCT, previous AMI, myocardial
fibrosis) and laboratory variables (glucose, TG, creatinine, TC, HDL, LDL, CPK,
CKMB, TnI) with pro-inflammatory potential in the behavior of this acute phase
inflammatory protein in both techniques employed.</p><p>Studies have shown small individual variations in serum concentrations of US-CRP in
different, yet very similar, age groups, between men and women<sup>[<xref rid="r26" ref-type="bibr">26</xref>-<xref rid="r28" ref-type="bibr">28</xref>]</sup>. Older individuals
tend to have greater stability in US-CRP blood levels<sup>[<xref rid="r29" ref-type="bibr">29</xref>]</sup>.</p><p>The two-way analysis of variance, contrary to our expectations, showed no correlation
between the area under the US-CRP curve and the subgroups analyzed
(<italic>P</italic>=0.127) or the applied treatment (<italic>P</italic>=0.207).
There was no prevalence of one myocardial revascularization technique over the other
in this study, despite the inflammatory profile of smokers and former smokers.</p><p>The strong link between AMI and serum levels of US-CRP is well demonstrated in the
literature<sup>[<xref rid="r30" ref-type="bibr">30</xref>]</sup>. US-CRP has been shown to be a good predictor of
recurrence of new coronary events in patients who have already suffered a heart
attack<sup>[<xref rid="r31" ref-type="bibr">31</xref>]</sup>. Significantly, more patients with previous AMI
were allocated to Group 2 (<xref rid="t1" ref-type="table">Table 1</xref>).</p><p>Regarding this finding, there was no difference in the mean left ventricular ejection
fraction (LVEF) between Group 1 (63%) and Group 2 (62%). Hypothetically, there was a
bias trend of results due to the inflammatory profile of Group 2 patients.</p><p>In contrast to the previous hypothesis, after the correlation between the area under
the US-CRP curve and the previous AMI variable, no interaction was observed in the
ONCAB group or in relation to the effect of the treatment in face of the CABG
techniques employed.</p><p>This study showed that there was no preferential CABG technique for patients with
AMI, when the US-CRP behavior was analyzed.</p><p>We can conclude this discussion by stating that, in relation to the known demographic
profile and variables, to predict a worse postoperative prognosis in patients
submitted to ONCAB or OPCAB, this study, through the analysis of a reliable
inflammatory response marker, revealed that both myocardium revascularization
surgery techniques, on or off-pump, promote an increase in the inflammatory
response, increasing preoperative to postoperative US-CRP values.</p></sec><sec sec-type="conclusions"><title>CONCLUSION</title><p>There was an increase in US-CRP in the postoperative period compared to the
preoperative period. This increase occurred in all moments assessed postoperatively.
There was no difference in the US-CRP behavior between the two myocardial
revascularization techniques employed. We inferred that there was an increase the
inflammatory process based on the behavior of the US-CRP from the preoperative to
the postoperative period, without evidence of correlation with the biological
variables (except CPK in the ONCAB group) and the operative techniques employed.</p><table-wrap id="t3" orientation="portrait" position="anchor"><table frame="hsides" rules="groups"><colgroup span="1"><col width="5%" span="1"/><col width="95%" span="1"/></colgroup><thead><tr><th align="left" colspan="2" rowspan="1"><bold>Authors&#x02019; roles &#x00026;
responsibilities</bold></th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">RDA</td><td align="left" rowspan="1" colspan="1">Substantial contributions to the conception or design
of the work; or the acquisition, analysis, or interpretation of data
for the work; final approval of the version to be published</td></tr><tr><td align="left" rowspan="1" colspan="1">ACH</td><td align="left" rowspan="1" colspan="1">Substantial contributions to the conception or design
of the work; or the acquisition, analysis, or interpretation of data
for the work; final approval of the version to be published</td></tr><tr><td align="left" rowspan="1" colspan="1">WH</td><td align="left" rowspan="1" colspan="1">Substantial contributions to the conception or design
of the work; or the acquisition, analysis, or interpretation of data
for the work; final approval of the version to be published</td></tr><tr><td align="left" rowspan="1" colspan="1">FBJ</td><td align="left" rowspan="1" colspan="1">Drafting the work or revising it critically for
important intellectual content; final approval of the version to be
published</td></tr></tbody></table></table-wrap></sec></body><back><fn-group><fn fn-type="other"><p>This study was carried out at Instituto do Cora&#x000e7;&#x000e3;o do Hospital das
Cl&#x000ed;nicas da Faculdade de Medicina da Universidade de S&#x000e3;o Paulo
(InCor-HCFMUSP), S&#x000e3;o Paulo, SP, Brazil.</p></fn><fn fn-type="financial-disclosure"><p>No financial support.</p></fn><fn fn-type="COI-statement"><p>No conflict of interest.</p></fn></fn-group><ref-list><title>REFERENCES</title><ref id="r1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tillett</surname><given-names>WS</given-names></name><name><surname>Francis</surname><given-names>T</given-names></name></person-group><article-title>Serological reactions in pneumonia with a non-protein somatic
fraction of pneumococcus</article-title><source>J Exp Med</source><year>1930</year><volume>52</volume><issue>4</issue><fpage>561</fpage><lpage>571</lpage><pub-id pub-id-type="pmid">19869788</pub-id></element-citation></ref><ref id="r2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lofstrom</surname><given-names>G</given-names></name></person-group><article-title>Nonspecific capsular swelling in pneumococci: a serologic and
clinical study</article-title><source>Acta Med Scand</source><year>1943</year><volume>141</volume><fpage>3</fpage><lpage>98</lpage></element-citation></ref><ref id="r3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kroop</surname><given-names>IG</given-names></name><name><surname>Shackman</surname><given-names>NH</given-names></name></person-group><article-title>Level of C-reactive protein as a measure of acute myocardial
infarction</article-title><source>Proc Soc Exp Biol Med</source><year>1954</year><volume>86</volume><issue>1</issue><fpage>95</fpage><lpage>97</lpage><pub-id pub-id-type="pmid">13177599</pub-id></element-citation></ref><ref id="r4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pepys</surname><given-names>MB</given-names></name><name><surname>Hirschfield</surname><given-names>GM</given-names></name></person-group><article-title>C-reactive protein: a critical update</article-title><source>J Clin Invest</source><year>2003</year><volume>111</volume><issue>12</issue><fpage>1805</fpage><lpage>1812</lpage><pub-id pub-id-type="pmid">12813013</pub-id></element-citation></ref><ref id="r5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shrivastava</surname><given-names>AK</given-names></name><name><surname>Singh</surname><given-names>HV</given-names></name><name><surname>Raizada</surname><given-names>A</given-names></name><name><surname>Singh</surname><given-names>SK</given-names></name></person-group><article-title>C-reactive protein, inflammation and coronary heart
disease</article-title><source>Egyptian Heart J</source><year>2015</year><volume>67</volume><issue>2</issue><fpage>89</fpage><lpage>97</lpage></element-citation></ref><ref id="r6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yousuf</surname><given-names>O</given-names></name><name><surname>Mohanty</surname><given-names>BD</given-names></name><name><surname>Martin</surname><given-names>SS</given-names></name><name><surname>Joshi</surname><given-names>PH</given-names></name><name><surname>Blaha</surname><given-names>MJ</given-names></name><name><surname>Nasir</surname><given-names>K</given-names></name><etal/></person-group><article-title>High-sensitivity C-reactive protein and cardiovascular disease: a
resolute belief or an elusive link?</article-title><source>J Am Coll Cardiol</source><year>2013</year><volume>62</volume><issue>5</issue><fpage>397</fpage><lpage>408</lpage><pub-id pub-id-type="pmid">23727085</pub-id></element-citation></ref><ref id="r7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Madjid</surname><given-names>M</given-names></name><name><surname>Willerson</surname><given-names>JT</given-names></name></person-group><article-title>Inflammatory markers in coronary heart disease</article-title><source>Br Med Bull</source><year>2011</year><volume>100</volume><fpage>23</fpage><lpage>38</lpage><pub-id pub-id-type="pmid">22010105</pub-id></element-citation></ref><ref id="r8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lobo Filho</surname><given-names>JG</given-names></name><name><surname>Dantas</surname><given-names>MCBR</given-names></name><name><surname>Rolim</surname><given-names>JGV</given-names></name><name><surname>Rocha</surname><given-names>JA</given-names></name><name><surname>Oliveira</surname><given-names>FM</given-names></name><name><surname>Ciarline</surname><given-names>C</given-names></name><etal/></person-group><article-title>Cirurgia de revasculariza&#x000e7;&#x000e3;o completa do
mioc&#x000e1;rdio sem circula&#x000e7;&#x000e3;o extracorp&#x000f3;rea: uma
realidade</article-title><source>Rev Bras Cir Cardiovasc</source><year>1997</year><volume>12</volume><issue>2</issue><fpage>115</fpage><lpage>121</lpage></element-citation></ref><ref id="r9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moura</surname><given-names>HV</given-names></name><name><surname>Pomerantzeff</surname><given-names>PMA</given-names></name><name><surname>Gomes</surname><given-names>WJ</given-names></name></person-group><article-title>Systemic inflammatory response syndrome: role of the
interleukins</article-title><source>Rev Bras Cir Cardiovasc</source><year>2001</year><volume>16</volume><issue>4</issue><fpage>376</fpage><lpage>387</lpage></element-citation></ref><ref id="r10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kolessov</surname><given-names>VI</given-names></name></person-group><article-title>Mammary artery-coronary artery anastomosis as a method of
treatment for angina pectoris</article-title><source>J Thorac Cardiovasc Surg</source><year>1967</year><volume>54</volume><issue>4</issue><fpage>533</fpage><lpage>544</lpage></element-citation></ref><ref id="r11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mota</surname><given-names>AL</given-names></name><name><surname>Rodrigues</surname><given-names>AJ</given-names></name><name><surname>&#x000c9;vora</surname><given-names>PRB</given-names></name></person-group><article-title>Circula&#x000e7;&#x000e3;o extracorp&#x000f3;rea em adultos do
s&#x000e9;culo XXI. Ci&#x000ea;ncia, arte ou empirismo?</article-title><source>Rev Bras Cir Cardiovasc</source><year>2008</year><volume>23</volume><issue>1</issue><fpage>78</fpage><lpage>92</lpage><pub-id pub-id-type="pmid">18719832</pub-id></element-citation></ref><ref id="r12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buffolo</surname><given-names>E</given-names></name><name><surname>Gomes</surname><given-names>WJ</given-names></name><name><surname>Andrade</surname><given-names>JC</given-names></name><name><surname>Branco</surname><given-names>JN</given-names></name><name><surname>Maluf</surname><given-names>MA</given-names></name><name><surname>Palma</surname><given-names>JH</given-names></name><etal/></person-group><article-title>Revasculariza&#x000e7;&#x000e3;o mioc&#x000e1;rdica sem
circula&#x000e7;&#x000e3;o extracorp&#x000f3;rea: resultados cir&#x000fa;rgicos
em 1090 pacientes</article-title><source>Arq Bras Cardiol</source><year>1994</year><volume>62</volume><issue>3</issue><fpage>149</fpage><lpage>153</lpage><pub-id pub-id-type="pmid">7980074</pub-id></element-citation></ref><ref id="r13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buffolo</surname><given-names>E</given-names></name><name><surname>Andrade</surname><given-names>JC</given-names></name><name><surname>Succi</surname><given-names>JE</given-names></name><name><surname>Le&#x000e3;o</surname><given-names>LE</given-names></name><name><surname>Cueva</surname><given-names>C</given-names></name><name><surname>Branco</surname><given-names>JN</given-names></name><etal/></person-group><article-title>Revasculariza&#x000e7;&#x000e3;o do mioc&#x000e1;rdio sem
circula&#x000e7;&#x000e3;o extracorp&#x000f3;rea: descri&#x000e7;&#x000e3;o da
t&#x000e9;cnica e resultados iniciais</article-title><source>Arq Bras Cardiol</source><year>1983</year><volume>41</volume><issue>4</issue><fpage>309</fpage><lpage>316</lpage><pub-id pub-id-type="pmid">6609692</pub-id></element-citation></ref><ref id="r14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buffolo</surname><given-names>E</given-names></name><name><surname>Andrade</surname><given-names>JC</given-names></name><name><surname>Succi</surname><given-names>J</given-names></name><name><surname>Le&#x000e3;o</surname><given-names>LE</given-names></name><name><surname>Gallucci</surname><given-names>C</given-names></name></person-group><article-title>Direct myocardial revascularization without cardiopulmonary
bypass</article-title><source>Thorac Cardiovasc Surg</source><year>1985</year><volume>33</volume><issue>1</issue><fpage>26</fpage><lpage>29</lpage><pub-id pub-id-type="pmid">2579458</pub-id></element-citation></ref><ref id="r15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benetti</surname><given-names>FJ</given-names></name><name><surname>Naselli</surname><given-names>G</given-names></name><name><surname>Wood</surname><given-names>M</given-names></name><name><surname>Geffner</surname><given-names>L</given-names></name></person-group><article-title>Direct myocardial revascularization without extracorporeal
circulation. Experience in 700 patients</article-title><source>Chest</source><year>1991</year><volume>100</volume><issue>2</issue><fpage>312</fpage><lpage>316</lpage><pub-id pub-id-type="pmid">1677884</pub-id></element-citation></ref><ref id="r16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moller</surname><given-names>CH</given-names></name><name><surname>Penninga</surname><given-names>L</given-names></name><name><surname>Wetterslev</surname><given-names>J</given-names></name><name><surname>Steinbr&#x000fc;chel</surname><given-names>DA</given-names></name><name><surname>Gluud</surname><given-names>C</given-names></name></person-group><article-title>Off-pump versus on-pump coronary artery bypass grafting for
ischaemic heart disease</article-title><source>Cochrane Database Syst Rev</source><year>2012</year><issue>3</issue><elocation-id>CD007224</elocation-id><pub-id pub-id-type="pmid">22419321</pub-id></element-citation></ref><ref id="r17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hueb</surname><given-names>W</given-names></name><name><surname>Lopes</surname><given-names>NH</given-names></name><name><surname>Pereira</surname><given-names>AC</given-names></name><name><surname>Hueb</surname><given-names>AC</given-names></name><name><surname>Soares</surname><given-names>PR</given-names></name><name><surname>Favarato</surname><given-names>D</given-names></name><etal/></person-group><article-title>Five-year follow-up of a randomized comparison between off-pump
and on-pump stable multivessel coronary artery bypass grafting. The MASS III
Trial</article-title><source>Circulation</source><year>2010</year><volume>122</volume><issue>11</issue><supplement>Suppl</supplement><fpage>S48</fpage><lpage>S52</lpage><pub-id pub-id-type="pmid">20837925</pub-id></element-citation></ref><ref id="r18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shroyer</surname><given-names>AL</given-names></name><name><surname>Hattler</surname><given-names>B</given-names></name><name><surname>Wagner</surname><given-names>TH</given-names></name><name><surname>Collins</surname><given-names>JF</given-names></name><name><surname>Baltz</surname><given-names>JH</given-names></name><name><surname>Quin</surname><given-names>JA</given-names></name><etal/><collab>Veterans Affairs ROOBY-FS Group</collab></person-group><article-title>Five-year outcomes after on-pump and off-pump coronary-artery
bypass</article-title><source>N Engl J Med</source><year>2017</year><volume>377</volume><issue>7</issue><fpage>623</fpage><lpage>632</lpage><pub-id pub-id-type="pmid">28813218</pub-id></element-citation></ref><ref id="r19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Houlind</surname><given-names>K</given-names></name><name><surname>Kjeldsen</surname><given-names>BJ</given-names></name><name><surname>Madsen</surname><given-names>SN</given-names></name><name><surname>Rasmussen</surname><given-names>BS</given-names></name><name><surname>Holme</surname><given-names>SJ</given-names></name><name><surname>Schmidt</surname><given-names>TA</given-names></name><etal/><collab>DOORS Study group</collab></person-group><article-title>The impact of avoiding cardiopulmonary bypass during coronary
artery bypass surgery in elderly patients: the Danish On-Pump Off-Pump
Randomisation Study (DOORS)</article-title><source>Trials</source><year>2009</year><volume>10</volume><fpage>47</fpage><lpage>47</lpage><pub-id pub-id-type="pmid">19575814</pub-id></element-citation></ref><ref id="r20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Diegeler</surname><given-names>A</given-names></name><name><surname>B&#x000f6;rgermann</surname><given-names>J</given-names></name><name><surname>Kappert</surname><given-names>U</given-names></name><name><surname>Breuer</surname><given-names>M</given-names></name><name><surname>B&#x000f6;ning</surname><given-names>A</given-names></name><name><surname>Ursulescu</surname><given-names>A</given-names></name><etal/><collab>GOPCABE Study Group</collab></person-group><article-title>Off-pump versus on-pump coronary-artery bypass grafting in
elderly patients</article-title><source>N Engl J Med</source><year>2013</year><volume>368</volume><issue>13</issue><fpage>1189</fpage><lpage>1198</lpage><pub-id pub-id-type="pmid">23477657</pub-id></element-citation></ref><ref id="r21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lamy</surname><given-names>A</given-names></name><name><surname>Devereaux</surname><given-names>PJ</given-names></name><name><surname>Prabhakaran</surname><given-names>D</given-names></name><name><surname>Hu</surname><given-names>S</given-names></name><name><surname>Piegas</surname><given-names>LS</given-names></name><name><surname>Straka</surname><given-names>Z</given-names></name><etal/></person-group><article-title>Rationale and design of the coronary artery bypass grafting
surgery off or on pump revascularization study: a large international
randomized trial in cardiac surgery</article-title><source>Am Heart J</source><year>2012</year><volume>163</volume><issue>1</issue><fpage>1</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">22172429</pub-id></element-citation></ref><ref id="r22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lamy</surname><given-names>A</given-names></name><name><surname>Devereaux</surname><given-names>PJ</given-names></name><name><surname>Prabhakaran</surname><given-names>D</given-names></name><name><surname>Taggart</surname><given-names>DP</given-names></name><name><surname>Hu</surname><given-names>S</given-names></name><name><surname>Paolasso</surname><given-names>E</given-names></name><etal/><collab>CORONARY Investigators</collab></person-group><article-title>Off-pump or on-pump coronary-artery bypass grafting at 30
days</article-title><source>N Engl J Med</source><year>2012</year><volume>366</volume><issue>16</issue><fpage>1489</fpage><lpage>1497</lpage><pub-id pub-id-type="pmid">22449296</pub-id></element-citation></ref><ref id="r23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lamy</surname><given-names>A</given-names></name><name><surname>Devereaux</surname><given-names>PJ</given-names></name><name><surname>Prabhakaran</surname><given-names>D</given-names></name><name><surname>Taggart</surname><given-names>DP</given-names></name><name><surname>Hu</surname><given-names>S</given-names></name><name><surname>Paolasso</surname><given-names>E</given-names></name><etal/></person-group><article-title>CORONARY Investigators Effects of off-pump and on-pump
coronary-artery bypass grafting at 1 year</article-title><source>N Engl J Med</source><year>2013</year><volume>368</volume><issue>13</issue><fpage>1179</fpage><lpage>1188</lpage><pub-id pub-id-type="pmid">23477676</pub-id></element-citation></ref><ref id="r24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lamy</surname><given-names>A</given-names></name><name><surname>Devereaux</surname><given-names>PJ</given-names></name><name><surname>Prabhakaran</surname><given-names>D</given-names></name><name><surname>Taggart</surname><given-names>DP</given-names></name><name><surname>Hu</surname><given-names>S</given-names></name><name><surname>Straka</surname><given-names>Z</given-names></name><etal/><collab>CORONARY Investigators</collab></person-group><article-title>Five-year outcomes after off-pump or on-pump coronary-artery
bypass grafting</article-title><source>N Engl J Med</source><year>2016</year><volume>375</volume><issue>24</issue><fpage>2359</fpage><lpage>2368</lpage><pub-id pub-id-type="pmid">27771985</pub-id></element-citation></ref><ref id="r25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hueb</surname><given-names>W</given-names></name><name><surname>Gersh</surname><given-names>BJ</given-names></name><name><surname>Costa</surname><given-names>LMA</given-names></name><name><surname>Oikawa</surname><given-names>FTC</given-names></name><name><surname>Melo</surname><given-names>RMV</given-names></name><name><surname>Rezende</surname><given-names>PC</given-names></name><etal/></person-group><article-title>Accuracy of myocardial biomarkers in the diagnosis of myocardial
infarction after revascularization as assessed by cardiac resonance: the
Medicine, Angioplasty, Surgery Study V (MASS-V) Trial</article-title><source>Ann Thorac Surg</source><year>2016</year><volume>101</volume><issue>6</issue><fpage>2202</fpage><lpage>2208</lpage><pub-id pub-id-type="pmid">26912303</pub-id></element-citation></ref><ref id="r26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Han</surname><given-names>SS</given-names></name><name><surname>Kim</surname><given-names>DK</given-names></name><name><surname>Kim</surname><given-names>S</given-names></name><name><surname>Chin</surname><given-names>HJ</given-names></name><name><surname>Chae</surname><given-names>DW</given-names></name><name><surname>Na</surname><given-names>KY</given-names></name></person-group><article-title>C-reactive protein predicts acute kidney injury and death after
coronary artery bypass grafting</article-title><source>Ann Thorac Surg</source><year>2017</year><volume>104</volume><issue>3</issue><fpage>804</fpage><lpage>810</lpage><pub-id pub-id-type="pmid">28433221</pub-id></element-citation></ref><ref id="r27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nezami</surname><given-names>N</given-names></name><name><surname>Djavadzadegan</surname><given-names>H</given-names></name><name><surname>Tabatabaie-Adl</surname><given-names>H</given-names></name><name><surname>Hamdi</surname><given-names>A</given-names></name><name><surname>Ghobadi</surname><given-names>K</given-names></name><name><surname>Ghorashi</surname><given-names>S</given-names></name><etal/></person-group><article-title>On- versus off-pump coronary artery bypass grafting: no
difference in early postoperative kidney function based on TNF-a or
C-reactive protein</article-title><source>Cardiorenal Med</source><year>2012</year><volume>2</volume><issue>3</issue><fpage>190</fpage><lpage>199</lpage><pub-id pub-id-type="pmid">22969775</pub-id></element-citation></ref><ref id="r28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gerritsen</surname><given-names>WB</given-names></name><name><surname>van Boven</surname><given-names>WJ</given-names></name><name><surname>Driessen</surname><given-names>AH</given-names></name><name><surname>Haas</surname><given-names>FJ</given-names></name><name><surname>Aarts</surname><given-names>LP</given-names></name></person-group><article-title>Off-pump versus on-pump coronary artery bypass grafting:
oxidative stress and renal function</article-title><source>Eur J Cardiothorac Surg</source><year>2001</year><volume>20</volume><issue>5</issue><fpage>923</fpage><lpage>929</lpage><pub-id pub-id-type="pmid">11675176</pub-id></element-citation></ref><ref id="r29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loef</surname><given-names>BG</given-names></name><name><surname>Epema</surname><given-names>AH</given-names></name><name><surname>Navis</surname><given-names>G</given-names></name><name><surname>Ebels</surname><given-names>T</given-names></name><name><surname>van Oeveren</surname><given-names>W</given-names></name><name><surname>Henning</surname><given-names>RH</given-names></name></person-group><article-title>Off-pump coronary revascularization attenuates transient renal
damage compared with on-pump coronary revascularization</article-title><source>Chest</source><year>2002</year><volume>121</volume><issue>4</issue><fpage>1190</fpage><lpage>1194</lpage><pub-id pub-id-type="pmid">11948052</pub-id></element-citation></ref><ref id="r30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beer</surname><given-names>FC</given-names></name><name><surname>Hind</surname><given-names>CR</given-names></name><name><surname>Fox</surname><given-names>KM</given-names></name><name><surname>Allan</surname><given-names>RM</given-names></name><name><surname>Maseri</surname><given-names>A</given-names></name><name><surname>Pepys</surname><given-names>MB</given-names></name></person-group><article-title>Measurement of serum C-reactive protein concentration in
myocardial ischemia and infarction</article-title><source>Br Heart J</source><year>1982</year><volume>47</volume><issue>3</issue><fpage>239</fpage><lpage>243</lpage><pub-id pub-id-type="pmid">7059401</pub-id></element-citation></ref><ref id="r31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ridker</surname><given-names>P</given-names></name><name><surname>Rifai</surname><given-names>N</given-names></name><name><surname>Pfeffer</surname><given-names>M</given-names></name><name><surname>Sacks</surname><given-names>FM</given-names></name><name><surname>Moye</surname><given-names>LA</given-names></name><name><surname>Goldman</surname><given-names>S</given-names></name><etal/></person-group><article-title>Inflammation, pravastatin, and the risk of coronary events after
myocardial infarction in patients with average cholesterol levels.
Cholesterol and Recurrent Events (CARE) Investigators</article-title><source>Circulation</source><year>1998</year><volume>98</volume><issue>9</issue><fpage>839</fpage><lpage>844</lpage><pub-id pub-id-type="pmid">9738637</pub-id></element-citation></ref></ref-list></back></article>